Concord Medical Services (NYSE:CCM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a report issued on Sunday. The firm issued a sell rating on the stock.

Concord Medical Services Price Performance

NYSE:CCM opened at $4.36 on Friday. Concord Medical Services has a 12-month low of $3.82 and a 12-month high of $26.70. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.46 and a current ratio of 0.47. The stock’s fifty day simple moving average is $4.80 and its 200-day simple moving average is $5.50.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.